Medlive Technology Co., Ltd. disclosed that two batches of share-option exercises added a combined 295,000 ordinary shares to its issued share capital in early April 2026, marginally expanding the register by 0.04 percent.

The company issued: • 20,000 shares on 2 April 2026 following an employee’s option exercise; • 275,000 shares on 8 April 2026 after two directors exercised their options.

All shares were allotted at RMB 0.38 each under the Pre-IPO Share Option Scheme adopted on 29 March 2021.

As a result, Medlive’s outstanding ordinary share base rose from 738.96 million to 739.26 million. The company reported no treasury-share movements, repurchases or on-market sales during the period.

The filing was signed by Company Secretary Yang Yanling and confirmed compliance with Hong Kong listing regulations and related statutory requirements.